The drug-discovery company is to contribute its expertise in deep learning and foundation AI models, applied to extensive datasets on thousands of people from a new Human Longevity subsidiary called Human Life Foundation Models. They’re aiming for breakthroughs in predicting health risks, detecting age-related diseases early and creating new treatments. (The Logic)

Talking point: Insilico has operations on multiple continents but much of its core AI work is led in Montreal; founder Alex Zhavoronkov is Canadian, as is Insilico’s head of AI platforms, Petrina Kamya. Last week, the company revealed that it’s been working with Saudi Aramco on AI-driven materials-science work. Also, after going public on the Hong Kong stock exchange at the end of 2025, Insilico is considering a secondary listing in Abu Dhabi, according to Bloomberg. Kamya has previously told The Logic that the United Arab Emirates was a friendly refuge for Insilico AI specialists fleeing Russia’s war on Ukraine.